Skip to main content

Table 1 Patient characteristics

From: Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial

 

Overall (n=57)

GnRH (n=22)

DNG (n=27)

P value

Age [years]

33.0 ± 5.6

33.0 ± 5.7

33.0 ± 5.5

0.83 a

Cyst size [cm]

7 [5-8]

5.5 [4.6-8]

7 [5.2-8]

0.26 b

Surgery

    

Unilateral / Bilateral

[n (%)]

34 (59) / 23 (41)

12 (54) / 10 (45)

17 (62) / 10 (38)

0.57 c

rASRM score

57 [36-78]

48 [37-64]

63 [37-85]

0.35 b

Operation time [min]

130 ± 39

123 ± 38

135 ± 39

0.28 a

Blood loss [ml]

51 [4.5-204]

50 [4.5-138]

95 [8.5-216]

0.31 b

Total time of use of hemostasis [s]

16 ± 10

12 ± 8.9

18 ± 10

0.32 a

Patient number of resection of follicles in specimens

[n (%)]

21 (40)

8 (36)

13 (43)

0.77 d

Serum FSH [mlU/mL]

    

pre-treatment

6.0 [4.8-7.2]

5.8 [4.9-8.4]

6.2 [4.5-6.9]

0.81 b

postoperative 2 month (4 M)

5.8 [3.9-7.1]

4.8 [3.1-5.7]

6.6 [4.5-7.2]

0.018 b

postoperative 6 month (8 M)

5.7 [4.8-9.0]

4.6 [3.8-10.2]

5.5 [4.9-7.4]

0.64 b

postoperative 1 year

(14 M)

6.5 [4.2-7.9]

8.5 [6.7-11.4]

5.9 [3.8-9.1]

0.014 b

Serum AMH [ng/mL]

    

pre-treatment

2.3 [1.1-3.8]

2.3 [1.1-4.0]

2.2 [1.1-3.2]

0.54 b

postoperative 2 month (4 M)

1.5 [0.63-2.0]

1.5 [0.84-2.1]

1.3 [0.54-2.0]

0.43 b

postoperative 6 month (8 M)

1.1 [0.56-2.0]

1.0 [0.68-2.1]

1.2 [0.42-2.0]

0.69 b

postoperative 1 year

(14 M)

1.0 [0.50-2.3]

0.79 [0.48-2.2]

1.3 [0.64-2.7]

0.10 b

 

Overall (n=32)

GnRH (n=15)

DNG (n=17)

P value

Pregnancy [n (%)]

10 (31)

6 (40)

4 (23)

0.45 d

  1. Note: The values are presented as the mean ± standard division (SD) or median [25th, 75th percentile]
  2. a. Student’s t-test
  3. b. Mann-Whitney U test
  4. c. Chi-square test
  5. d. Fisher’s exact test